An intelligent re-shieldable targeting system for enhanced tumor accumulation
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Tianjin
PCSIRT
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference54 articles.
1. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007
2. Stimuli-responsive programmed specific targeting in nanomedicine;Wang;ACS Nano,2016
3. Stimuli-responsive nanocarriers for drug delivery;Mura;Nat. Mater.,2013
4. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug–drug conjugate for cancer therapy;Huang;J. Am. Chem. Soc.,2014
5. Strategies for advancing cancer nanomedicine;Chauhan;Nat. Mater.,2013
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications;AAPS PharmSciTech;2024-06-18
2. Iron-poly(tannic acid) biomimetic nanoparticles for targeted magnetic resonance imaging and drug delivery;Chinese Journal of Analytical Chemistry;2023-11
3. Advances in nanomaterial-based targeted drug delivery systems;Frontiers in Bioengineering and Biotechnology;2023-04-13
4. Coupling an artificial receptor with macrophage membrane for targeted and synergistic treatment of cholestasis;Supramolecular Materials;2022-12
5. Tumor microenvironment-responsive size-switchable drug delivery nanosystems;Expert Opinion on Drug Delivery;2022-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3